Thomas DiCioccio

Thomas DiCioccio, Ph.D., joined Regeneron in 2010 and serves as senior vice president, pharmacometrics. Dr. DiCioccio leads a team for four integrated functions: Preclinical & Translation PK/PD, and clinical and quantitative pharmacology with supporting efforts from a group of data scientists. Collectively, through integration of pharmacology with modeling and other quantitative methods, the functions within pharmacometrics play a central role in dose selection from first-in-human studies through global market applications as well as post-approval activities. The pharmacometric functions are also responsible for the associated documentation needed to support clinical protocols, as well as the nonclinical PK and clinical pharmacology summaries for the global regulatory filings. Prior to joining Regeneron, Dr. DiCioccio spent 14 years with a biotechnology start-up, after previously working with Lederle Laboratories for 14 years. Dr. DiCioccio earned an B.S. from SUNY Stony Brook, a M.S. at New York Medical College and a Ph.D. from Saint John’s University.